|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/145 | (2006.01) |
| C12Q 1/70 | (2006.01) |
| (11) | Number of the document | 2578229 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12193096.0 |
| Date of filing the European patent application | 2005-09-09 | |
| (97) | Date of publication of the European application | 2013-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2013-07-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 04255471 | 2004-09-09 | EP |
| (72) |
Gregersen, Jens Peter, DE
|
| (73) |
Novartis Vaccines and Diagnostics GmbH,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
|
| (54) | Decreasing potential iatrogenic risks associated with vaccine antigens |
| Decreasing potential iatrogenic risks associated with vaccine antigens |